IL66619A0 - Beta-lactams,their manufacture and their use as intermediates - Google Patents

Beta-lactams,their manufacture and their use as intermediates

Info

Publication number
IL66619A0
IL66619A0 IL66619A IL6661982A IL66619A0 IL 66619 A0 IL66619 A0 IL 66619A0 IL 66619 A IL66619 A IL 66619A IL 6661982 A IL6661982 A IL 6661982A IL 66619 A0 IL66619 A0 IL 66619A0
Authority
IL
Israel
Prior art keywords
manufacture
lactams
beta
readily cleavable
group
Prior art date
Application number
IL66619A
Other languages
English (en)
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL66619A0 publication Critical patent/IL66619A0/xx
Priority to IL76782A priority Critical patent/IL76782A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Fats And Perfumes (AREA)
IL66619A 1981-08-27 1982-08-23 Beta-lactams,their manufacture and their use as intermediates IL66619A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL76782A IL76782A (en) 1981-08-27 1985-10-22 Optically uniform glyceraldimine derivatives and their manufacture

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH552481 1981-08-27
CH392582 1982-06-25

Publications (1)

Publication Number Publication Date
IL66619A0 true IL66619A0 (en) 1982-12-31

Family

ID=25694185

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66619A IL66619A0 (en) 1981-08-27 1982-08-23 Beta-lactams,their manufacture and their use as intermediates

Country Status (15)

Country Link
US (3) US4576751A (xx)
EP (2) EP0073061B1 (xx)
KR (1) KR880000432B1 (xx)
AT (2) ATE30017T1 (xx)
AU (2) AU555097B2 (xx)
CA (1) CA1262128A (xx)
DE (2) DE3275543D1 (xx)
DK (1) DK168433B1 (xx)
ES (1) ES8401935A1 (xx)
HU (1) HU190697B (xx)
IE (1) IE53791B1 (xx)
IL (1) IL66619A0 (xx)
NO (1) NO159931C (xx)
NZ (1) NZ201660A (xx)
PH (1) PH21581A (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782147A (en) * 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
EP0096296B1 (de) * 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
CA1204746A (en) * 1982-08-19 1986-05-20 Hoffmann-La Roche Limited .beta. LACTAMS
US4663469A (en) * 1982-12-09 1987-05-05 Hoffman-La Roche Inc. 4-hydroxy-l-threoninamides
US4502994A (en) * 1982-12-09 1985-03-05 Hoffmann-La Roche Inc. Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate
CA1251454A (en) * 1983-01-20 1989-03-21 Gerard Schmid PROCESS FOR THE MANUFACTURE OF .beta.-LACTAMES
DK36784A (da) * 1983-02-25 1984-08-26 Hoffmann La Roche Fremgangsmaade til fremstilling af chirale aldehyder
US4501697A (en) * 1983-06-17 1985-02-26 E. R. Squibb & Sons, Inc. 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts
DK411384A (da) * 1983-10-03 1985-04-04 Hoffmann La Roche Fremgangsmaade til fremstilling af azetidinonderivater
EP0146735A1 (de) * 1983-11-23 1985-07-03 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Optisch einheitliche beta-Lactame
JPS60139667A (ja) * 1983-12-27 1985-07-24 Takeda Chem Ind Ltd アゼチジノンの製造法
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
US4937331A (en) * 1988-03-25 1990-06-26 President And Fellows Of Harvard College Chiral azetidinone epoxides
PL2197881T3 (pl) * 2007-09-17 2013-09-30 Basilea Pharmaceutica Ag Sposób wytwarzania związków pośrednich dla mostkowanych monobaktamów
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103044416A (zh) * 2012-12-17 2013-04-17 浙江华方药业有限责任公司 一种卡芦莫南钠的合成方法
AU2015236369B2 (en) 2014-03-24 2017-02-16 Novartis Ag Monobactam organic compounds for the treatment of bacterial infections
AU2016327264B2 (en) 2015-09-23 2019-06-27 Novartis Ag Salts and solid forms of monobactam antibiotic
US11414411B2 (en) 2017-08-02 2022-08-16 Novartis Ag Chemical process for manufacturing monobactam antibiotic and intermediates thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK194776A (da) * 1975-05-05 1976-11-06 Smithkline Corp Antibakterielle midler og mellemprodukter dertil
GB1570278A (en) * 1975-10-06 1980-06-25 Fujisawa Pharmaceutical Co O-substituted-2-azetidinone derivatives and the preparation thereof
JPS609514B2 (ja) * 1976-08-05 1985-03-11 塩野義製薬株式会社 7−アミノ−3′−ノルセファロスポラン酸類
US4202978A (en) * 1978-02-08 1980-05-13 Hoffmann-La Roche Inc. (S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines
US4473502A (en) * 1981-04-08 1984-09-25 Merck & Co., Inc. Synthesis of thienamycin via (3SR, 4RS)-3-[1 (SR)-hydroxyethyl]-2-oxo-4-azetidineacetic acid

Also Published As

Publication number Publication date
EP0073061B1 (de) 1987-03-04
ES515255A0 (es) 1984-01-16
NO159931C (no) 1989-02-22
ATE30017T1 (de) 1987-10-15
IE822067L (en) 1983-02-27
KR880000432B1 (ko) 1988-03-24
EP0073061A3 (en) 1983-06-15
CA1262128A (en) 1989-10-03
US4576751A (en) 1986-03-18
EP0156976A2 (de) 1985-10-09
DK168433B1 (da) 1994-03-28
PH21581A (en) 1987-12-11
US4699986A (en) 1987-10-13
DK373082A (da) 1983-02-28
EP0156976B1 (de) 1987-09-30
ES8401935A1 (es) 1984-01-16
AU8752382A (en) 1983-03-03
NZ201660A (en) 1986-01-24
IE53791B1 (en) 1989-02-15
DE3275543D1 (en) 1987-04-09
EP0073061A2 (de) 1983-03-02
NO822902L (no) 1983-02-28
DE3277410D1 (en) 1987-11-05
AU555097B2 (en) 1986-09-11
HU190697B (en) 1986-10-28
AU5467186A (en) 1986-07-31
NO159931B (no) 1988-11-14
US4617150A (en) 1986-10-14
ATE25676T1 (de) 1987-03-15
EP0156976A3 (en) 1986-06-04
AU576951B2 (en) 1988-09-08
KR840001135A (ko) 1984-03-28

Similar Documents

Publication Publication Date Title
DE3277410D1 (en) Optically uniform imines
SE8004652L (sv) Kontaktlins
DK251884A (da) Aluminiumresistent, keramisk fibersammensaetning
SE7901729L (sv) Ettiksyraderivat och sett for deras framstellning
DE3787333D1 (de) Zwischenprodukte für Antibiotika.
DE3564195D1 (en) Membrane of vinyl polymers and its use
GR3006948T3 (xx)
FR2383995B1 (xx)
SE7501375L (xx)
DE69416424D1 (de) Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte
ES470161A1 (es) Procedimiento para la preparacion de nuevos colorantes an- traquinonicos solubles en agua
WO2000066108A3 (en) Anticonvulsant derivatives useful in treating cocaine dependency
MY129238A (en) Anticonvulsant derivatives useful in treating essential tremor
JPS5754592B2 (xx)
ES451975A1 (es) Procedimiento para la preparacion de diesteres de tetrabro- moxilileno.
ES8306756A1 (es) Un procedimiento para la preparacion de un enantiomero de beta-lactama.
NO168590C (no) Fremgangsmaate for fremstilling av diorganopolysiloksangruppe
GB190518874A (en) An Improvement in Fountain or Stylographic Pens.
SE8306046D0 (sv) 5-fenoxibensoesyraderivat av pentiten, sett for framstellning av dessa foreningar samt medel med herbicid verkan innehallande dem

Legal Events

Date Code Title Description
RH Patent void